By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pharmalink AB 

Karlavägen 18

Stockholm    SE-102 49  Sweden
Phone: 46-0-8-505-66-312 Fax: 46-0-8-611-3303


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pharmalink AB Strengthens Its Management Team. Appoints New Chief Financial Officer And Head Of Communications 8/15/2017 9:07:06 AM
Positive Phase IIb Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Presented At Leading Kidney Disease Conference 6/5/2017 8:34:49 AM
Positive Phase IIb Trial Of Pharmalink AB’s Nefecon In Primary IgA Nephropathy Selected For Presentation At Leading Kidney Disease Conference 5/31/2017 12:33:54 PM
Pharmalink AB Announces The Appointment Of A New Chief Executive Officer 5/18/2017 6:55:59 AM
Positive Results Of Phase IIb Clinical Trial Of Pharmalink AB's Nefecon In Primary IgA Nephropathy Published In The Lancet 3/29/2017 7:37:37 AM
Pharmalink AB Strengthens Board With Appointment Of Maria Carell As Chair 1/9/2017 11:48:46 AM
Pharmalink AB Announces European Orphan Drug Designation For Nefecon For Treatment Of Iga Nephropathy, An Inflammatory Kidney Disease 11/29/2016 9:47:50 AM
Pharmalink AB Raises SEK100m To Advance Nefecon Development As New Treatment For Kidney Disease 10/1/2015 6:11:56 AM
Pharmalink AB Phase II Trial Of Nefecon Halted Early 4/14/2015 6:15:40 AM
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015 6:41:50 AM
123
//-->